Shopping Cart
- Remove All
- Your shopping cart is currently empty
THPP-1 is a potent and orally bioavailable inhibitor of PDE10A(Ki of 1 nM and 1.3 nM for human and rat PDE10A, respectively).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | 40 € | In Stock | |
10 mg | 69 € | In Stock | |
25 mg | 150 € | In Stock | |
50 mg | 254 € | In Stock | |
100 mg | 375 € | In Stock | |
200 mg | 534 € | In Stock | |
1 mL x 10 mM (in DMSO) | 41 € | In Stock |
Description | THPP-1 is a potent and orally bioavailable inhibitor of PDE10A(Ki of 1 nM and 1.3 nM for human and rat PDE10A, respectively). |
Targets&IC50 | PDE10A:1-1.3 nM |
In vivo | Consistent with rodent data, both THPP-1 and risperidone significantly attenuated the stimulant effects in SIMA when administered alone, though some differences were noted.?Combination therapy with a low dose of risperidone produced significantly more robust effects.?THPP-1 and risperidone also produced a marked reduction of wake cycle time and gamma frequency power in EEG.?However, THPP-1 differed from risperidone by reducing spectral power of lower frequencies[1]. |
Molecular Weight | 464.9 |
Formula | C23H21ClN6O3 |
Cas No. | 1257051-63-0 |
Smiles | COCCOc1nc(nc2CCN(Cc12)C(=O)c1ncn2ccccc12)-c1ccc(Cl)nc1 |
Relative Density. | 1.45 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 31 mg/mL (66.68 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.